After 45 and 90 days, a number of parameters improved, including reductions in body weight, HbA1c, fibroblast growth factor 21 (FGF21), insulin resistance measured by HOMA-IR, hepatic steatosis index (HIS), and triglycerides, as shown in Table 1. This evidence concerns the gene FGF21 and fatty liver disease.